Guided Therapeutics, Inc.
GTHP
$0.29
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.93% | 19.19% | 30.73% | 56.19% | 59.25% |
| Total Depreciation and Amortization | 11.11% | 10.23% | 11.76% | 10.71% | 11.11% |
| Total Amortization of Deferred Charges | 54.78% | -1.54% | -28.46% | -18.60% | -11.54% |
| Total Other Non-Cash Items | 837.14% | -92.47% | -93.45% | -102.19% | -99.00% |
| Change in Net Operating Assets | -22.19% | 129.62% | 1,055.24% | 647.56% | 410.73% |
| Cash from Operations | -16.21% | -0.22% | 35.91% | 35.79% | 40.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 373.50% | -- | -- | -- | -- |
| Total Debt Repaid | -32.81% | -102.10% | -15.78% | 29.19% | 38.06% |
| Issuance of Common Stock | 246.47% | 246.47% | 91.51% | 137.28% | -85.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -235.29% | -- | -- | -- | -100.95% |
| Cash from Financing | 2,937.50% | 2,366.67% | 3,716.67% | 373.83% | -98.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.69% | 76.29% | 88.21% | 72.69% | -218.75% |